Complete Response to Nivolumab and Ipilimumab After Pazopanib Discontinuation in a Seven‐Year‐Old Girl With Alveolar Soft Part Sarcoma: A Case Report and Literature Review
This case highlights the value of ICIs as potential treatment options for ASPS in the pediatric population, especially in patients who cannot tolerate TKIs' side effects.
Authors
- Aziz Eghbali (ORCID: https://orcid.org/0000-0002-5118-0094)
- Mobin Obeidinia (ORCID: https://orcid.org/0000-0003-3202-0041)
- AM Shirani (ORCID: https://orcid.org/0000-0003-4878-3721)
- Hamideh Sadat Mirmohammadi
- Roghayeh Rahimiafazal
Institutions
- Iran University of Medical Sciences (IR)
- Firoozgar General Hospital (IR)
- Shahid Beheshti University of Medical Sciences (IR)
- Tehran University of Medical Sciences (IR)
Publication Details
- Journal
- Cancer Reports
- Published
- 2025-08-01
- DOI
- https://doi.org/10.1002/cnr2.70305
- Citations
- 1
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 1.05